Literature DB >> 7655387

Kinetic and organ-specific patterns of cytokine expression in acute graft-versus-host disease.

K S Baker1, R D Allen, J B Roths, C L Sidman.   

Abstract

Although many cytokines have been previously implicated in graft-versus-host disease (GVHD), no study to date has comprehensively evaluated their expression over time or in different tissues affected by GVHD. Using a semi-quantitative reverse transcriptase-PCR technique and a murine model of acute GVHD, we have evaluated the expression levels of mRNA for a wide range of cytokines in spleen, gut and liver tissues at weekly intervals after bone marrow transfer. The earliest cytokine responses seen were increases in IL-2, IL-10, IFN-gamma, MIP-1 alpha and TNF-alpha in the spleen, suggesting a primarily Th1 pathway. Other cytokines (IL-1 alpha, IL-10 and MIP-1 alpha) were persistently elevated in GVHD mice, but were variable depending on the tissue. These data demonstrate that a wide range of cytokines are involved in the GVHD response and that their kinetic pattern of expression is different in various affected tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655387

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Kinetics of gene expression in murine cutaneous graft-versus-host disease.

Authors:  Philip B Sugerman; Sara B Faber; Lucy M Willis; Aleksandra Petrovic; George F Murphy; Jacques Pappo; David Silberstein; Marcel R M van den Brink
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

2.  Expression profiling of major histocompatibility and natural killer complex genes reveals candidates for controlling risk of graft versus host disease.

Authors:  Peter Novota; Severin Zinöcker; Jean Norden; Xiao Nong Wang; Lisbet Sviland; Lennart Opitz; Gabriela Salinas-Riester; Bent Rolstad; Anne M Dickinson; Lutz Walter; Ralf Dressel
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

3.  Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients.

Authors:  Karin Melanie Cabanillas Stanchi; Manon Queudeville; Carmen Malaval; Judith Feucht; Patrick Schlegel; Markus Dobratz; Christian Seitz; Ingo Müller; Peter Lang; Rupert Handgretinger; Michaela Döring
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-24       Impact factor: 4.322

4.  Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation.

Authors:  Michaela Döring; Karin Melanie Cabanillas Stanchi; Markus Mezger; Annika Erbacher; Judith Feucht; Matthias Pfeiffer; Peter Lang; Rupert Handgretinger; Ingo Müller
Journal:  BMC Cancer       Date:  2015-08-28       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.